Metformin: First pill that purportedly treats age-related illnesses in review for approval for trials

dsm metformin in healthy aging

In recent decades, we’ve come leaps and bounds in treating and preventing some of the world’s leading age-related diseases, such as coronary heart disease, dementia and Alzheimer’s disease.

But some research takes an entirely unique view on the role of science in easing the burden of aging, focusing instead on trying to prevent it, or drastically slow it down. This may seem like an idea reserved mainly for cranks and science fiction writers, but it’s not.

The drug metformin, usually prescribed to manage type 2 diabetes, has also been touted as a way to delay the onset of a range of age-related diseases, thus increasing “health-span” (how long we remain healthy).


Nir Barzilai, director of the Institute for Aging Research at Yeshiva University’s Albert Einstein College of Medicine, is seeking approval from the US Food and Drug Administration for the first clinical trial of metformin to “treat” aging.

Related article:  For all types of life, genetic diversity is ‘about the same’

But other researchers are concerned, as metformin intake has been associated with a higher risk of B vitamin deficiencies. Some studies suggest this can result in cognitive dysfunction.

Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

Would a “cure” for aging be abused by the wealthy? Would knowing we had longer to live decrease our motivation in life?

Perhaps it’s a good thing we won’t be diving into the fountain of youth any time soon—if ever.


Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend